Cargando…
Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
Endoplasmic reticulum (ER)-resident α-glucosidases I and II sequentially trim the three terminal glucose moieties on N-linked glycans attached to nascent glycoproteins. These reactions are the first steps of N-linked glycan processing and are essential for proper folding and function of many glycopr...
Autores principales: | Chang, Jinhong, Block, Timothy M., Guo, Ju-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114303/ https://www.ncbi.nlm.nih.gov/pubmed/23816430 http://dx.doi.org/10.1016/j.antiviral.2013.06.011 |
Ejemplares similares
-
Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents
por: Chang, Jinhong, et al.
Publicado: (2013) -
Peptide modulators of alpha-glucosidase
por: Roskar, Irena, et al.
Publicado: (2015) -
Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases—Not Glycolipid Processing Enzymes
por: Sayce, Andrew C., et al.
Publicado: (2016) -
Characterizing the selectivity of ER α-glucosidase inhibitors
por: O’Keefe, Sarah, et al.
Publicado: (2019) -
Current and Future Direct-Acting Antivirals Against COVID-19
por: Chan, Shiu-Wan
Publicado: (2020)